...
首页> 外文期刊>Current medicinal chemistry >Discovery and design of retinoic acid receptor and retinoid X receptor class- and subtype-selective synthetic analogs of all-trans-retinoic acid and 9-cis-retinoic acid.
【24h】

Discovery and design of retinoic acid receptor and retinoid X receptor class- and subtype-selective synthetic analogs of all-trans-retinoic acid and 9-cis-retinoic acid.

机译:全反式视黄酸和9-顺式视黄酸的视黄酸受体和类视黄醇X受体类和亚型选择性合成类似物的发现和设计。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This review presents a historical overview of the discoveries of retinoic acid receptor (RAR) and retinoid X receptor (RXR) class- and subtype-selective synthetic retinoids. These synthetic retinoids are conformationally restricted by having aromatic rings in place of the tetraene bond systems of all-trans- and 9-cis-retinoic acids. Events leading to the design and synthesis of such retinoid transcriptional agonists as RAR subtype beta,gamma-selective 6-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-2-naph-thalenecarboxylic acid (TTNN), the RARgamma-selective Z-oxime of 6-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenylcarbonyl)-2-naphthalenecarboxylic acid (SR11254), RAR-selective 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl) benzoic acid (TTAB), RXR-selective 4-[1-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-cyclopropyl] benzoic acid (SR11246), RXR-selective 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-2-methylpropenyl]benzoic acid (SR11345), andRARgamma-selective retinoid transcriptional antagonist 2-(6-carboxy-2-naphthalenyl)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1,3-dithiolane (SR11253) are described.
机译:这篇综述介绍了视黄酸受体(RAR)和类视黄醇X受体(RXR)类和亚型选择性合成类视黄醇的发现的历史回顾。这些合成的类视黄醇在结构上受到限制,因为它们具有芳香环来代替全反式和9-顺式-视黄酸的四烯键系统。导致设计和合成类视黄醇转录激动剂的事件,如RAR亚型β,γ选择性6-(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)-2-萘-萘甲酸(TTNN),6-(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基羰基)-2-萘甲酸的RARγ-选择性Z-肟(SR11254 ),RAR选择性4-(5,6,7,8-四氢-5,5,8,8-四甲基-2-蒽基)苯甲酸(TTAB),RXR选择性4- [1-(5,6 ,7,8-四氢-5,5,8,8-四甲基-2-萘基)-环丙基]苯甲酸(SR11246),RXR选择性4- [1-(5,6,7,8-tetrahydro-3 ,5,5,8,8-五甲基-2-萘基)-2-甲基丙烯基]苯甲酸(SR11345)和RARγ选择性类维生素A转录拮抗剂2-(6-羧基-2-萘基)-2-(5,6描述了,7,8-四氢-5,5,8,8-四甲基-2-萘基)-1,3-二硫杂环戊烷(SR11253)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号